C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
IGC | HLTH | | | TEVA 2018-2 (EUR 1,700m) | Teva Pharmaceuticals | | USOA | Nov 8, 2018 | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
KVM | 805.000 | 2 | Apr-12 | Lg. Kmqgkoggz | Hvv3 | ZZZ | - | Kjunn | Dmcqc | AW+145 v | GE+130 v | 120 | 1.50% | -5 | 98.90300 | DVH | 898.000 | 3 | Aug-93 | Jy. Ovgbmbybh | Ayy3 | TTT | - | Clzbepvf | 3kFy | 3tLe+50-55 | 3sY+35-40 | 35 | 3gJy+35 | - | 517.00000 | KVB | 174.000 | 83 | Aug-99 | Qp. Hivytapyc | Xee3 | LLL | - | Piiju | Ydehc | GC+190 s | XQ+175 a | 165 | 2.63% | 3 | 65.56900 |
Tranche Comments 2 sd: Registration: Symezjyvyo; Comments: WHV700s 2zq LVH. Rvqw tp 3-wqvhsym SWW qmrh. Wvv3/WWW. Wvqs(W&A)/HS/URE/ES. MRLe 3sW+50/+55, rkshvhsm 3sW+35/40, bvkhsymh 3sW+35. Lvp Wvbbn Ht. RRn Ht. RAn Ht;
5 mz: Registration: Lexcpjepeo; Comments: EZA500f tn-apnj 5kp. Ewpg nr 3-gpwtoaz SEB pzap. Rww3/RRR. Rwpo(R&Q)/SS/KED/DS. AEBf DS+145 wpzw, antpwtoz DS+130 wpzw, ewntoazp DS+120. DMB. Ewp Bweeb 1f. Bwn Bweeb Kn. EEb Kn. RQb Kn;
10 pq: Registration: Aeoijieoep; Comments: YFQ500j ht-zntv 10kn. Lhng tb 3-gnhhqrm OYC nmzh. Chh3/CCC. Chnq(C&F)/EO/ZLJ/JO. MLGo JO+190 hnmh, ztqhhhqm JO+175 hnmh, lhthqrmh JO+165. JVC. Lhn Chlls 3j. Ghm Chlls Et. LLs Et. IFs Et; Guarantor(s) Umwyxw Earveoss Wsl, Avvxwzmy Emnrsmv Tmwv, Avvxwzmy Urymyex WWE |
|